Beaumont seeking cancer patients with COVID-19 for national study

Posted at 8:35 AM, Aug 20, 2020
and last updated 2020-08-20 08:35:47-04

(WXYZ) — Beaumont Health announced Thursday it is seeking cancer patients who had COVID-19 for a study with the National Cancer Institute.

The NCI COVID-19 Cancer Patients Study (NCCAPS) will happen nationwide, but locally at Beaumont hospitals in Dearborn, Farmington Hills, Royal Oak and Troy. Researchers will collect blood samples, medical information, medical images and more for the study, and participants could be followed for up to two years.

“People with cancer are already facing the shock of a cancer diagnosis, the tribulations that accompany treatment, or the stress of survivorship. In addition, we’re learning people with cancer may be at higher risk of severe illness from COVID-19 because their cancer, or its treatment, has left them more vulnerable to complications,” said Dana Zakalik, M.D., professor of medicine and oncology, Oakland University William Beaumont School of Medicine; and director, Nancy and James Grosfeld Cancer Genetics Center, Beaumont Health. “This national study will help scientists answer key questions about COVID-19’s impact on cancer patients, as well as cancer’s impact on the course of COVID-19. The findings have the potential to influence the treatment of cancer patients with COVID-19 in the future.”

To participate, patients must be actively undergoing cancer treatment or follow-up care after treatment. It will not require additional hospital visits.

This study is open to adults who are receiving treatment for cancer and are waiting for COVID-19 test results or who have COVID-19 now. If a person enrolls in the study while waiting for their test results and it turns out they are not infected with the virus, they will no longer be part of the study.

The study will allow researchers to:

  • Learn more about the risk factors related to serious illness from COVID-19 in people who are having treatment for cancer.
  • Study how COVID-19 affects cancer treatment and the results of the treatment.
  • Find genetic risk factors and markers of serious illness from COVID-19 in people with cancer.
  • Create a bank of data, blood samples, and images from people with COVID-19 and cancer for future research.

To learn more about the study criteria, call the Cancer Clinical Trials Office at the Beaumont Research Institute at 248-551-7695.
Additional Coronavirus information and resources:

Click here for a page with resources including a COVID-19 overview from the CDC, details on cases in Michigan, a timeline of Governor Gretchen Whitmer's orders since the outbreak, coronavirus' impact on Southeast Michigan, and links to more information from the Michigan Department of Health and Human Services, the CDC and the WHO.

View a global coronavirus tracker with data from Johns Hopkins University.

See complete coverage on our Coronavirus Continuing Coverage page.

Visit our The Rebound Detroit, a place where we are working to help people impacted financially from the coronavirus. We have all the information on everything available to help you through this crisis and how to access it.